J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Fixes Record Date For Split/Sub-Division
Intimation of Record Date for Split/Sub-Division of equity shares29-08-2023
29-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of Annual General Meeting held on August 24, 2023 along with Scrutinizer''s Report.25-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the Annual General Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201524-08-2023
JB Chemicals gets USFDA nod to market generic medication
The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals Pharmaceuticals said in a regulatory filing.23-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Receipt Of ANDA Approval For Doxepin Hydrochloride Capsules USP From US FDA
Receipt of ANDA approval for Doxepin Hydrochloride Capsules USP from US FDA23-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Investors/Analysts call16-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of equity shares on exercise of Stock options pursuant to Employee Stock Option Scheme13-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Investors/analysts call with Management10-08-2023
J B Chemicals & Pharmaceuticals Results Earnings Call for Q1FY24
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.10-08-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting of extract of consolidated financial results for quarter ended on June 30, 202310-08-2023